| Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: a systematic review and meta-analysis EA Selvaraj, FE Mózes, ANA Jayaswal, MH Zafarmand, Y Vali, JA Lee, ... Journal of hepatology 75 (4), 770-785, 2021 | 196 | 2021 |
| Development and validation of hepamet fibrosis scoring system–a simple, noninvasive test to identify patients with nonalcoholic fatty liver disease with advanced fibrosis J Ampuero, R Pais, R Aller, R Gallego-Durán, J Crespo, C García-Monzón, ... Clinical Gastroenterology and Hepatology 18 (1), 216-225. e5, 2020 | 148 | 2020 |
| miRNAs in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis CH Liu, J Ampuero, A Gil-Gómez, R Montero-Vallejo, Á Rojas, ... Journal of hepatology 69 (6), 1335-1348, 2018 | 146 | 2018 |
| Genetic and epigenetic regulation in nonalcoholic fatty liver disease (NAFLD) JA Del Campo, R Gallego-Durán, P Gallego, L Grande International journal of molecular sciences 19 (3), 911, 2018 | 145 | 2018 |
| Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach? R Younes, O Govaere, S Petta, L Miele, D Tiniakos, A Burt, E David, ... Gut 71 (2), 382-390, 2022 | 141 | 2022 |
| Association of NAFLD with subclinical atherosclerosis and coronary-artery disease: meta-analysis J Ampuero, R Gallego-Durán, M Romero-Gómez Rev Esp Enferm Dig 107 (1), 10-6, 2015 | 135 | 2015 |
| MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C K Thabet, A Asimakopoulos, M Shojaei, M Romero-Gomez, A Mangia, ... Nature communications 7 (1), 12757, 2016 | 121 | 2016 |
| Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease R Younes, GP Caviglia, O Govaere, C Rosso, A Armandi, T Sanavia, ... Journal of hepatology 75 (4), 786-794, 2021 | 120 | 2021 |
| Diverse impacts of the rs58542926 E167K variant in TM6SF2 on viral and metabolic liver disease phenotypes M Eslam, A Mangia, T Berg, HLY Chan, WL Irving, GJ Dore, ML Abate, ... Hepatology 64 (1), 34-46, 2016 | 115 | 2016 |
| The effects of metabolic status on non‐alcoholic fatty liver disease‐related outcomes, beyond the presence of obesity J Ampuero, R Aller, R Gallego‐Durán, JM Banales, J Crespo, ... Alimentary pharmacology & therapeutics 48 (11-12), 1260-1270, 2018 | 107 | 2018 |
| IFN-λ3, not IFN-λ4, likely mediates IFNL3–IFNL4 haplotype–dependent hepatic inflammation and fibrosis M Eslam, D McLeod, KS Kelaeng, A Mangia, T Berg, K Thabet, WL Irving, ... Nature Genetics 49 (5), 795-800, 2017 | 100 | 2017 |
| Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH J Ampuero, R Aller, R Gallego-Durán, J Crespo, JL Calleja, ... Journal of Hepatology 73 (1), 17-25, 2020 | 92 | 2020 |
| An extra virgin olive oil rich diet intervention ameliorates the nonalcoholic steatohepatitis induced by a high‐fat “Western‐type” diet in mice E Jurado‐Ruiz, LM Varela, A Luque, G Berná, G Cahuana, ... Molecular nutrition & food research 61 (3), 1600549, 2017 | 80 | 2017 |
| A polymorphism in the Irisin-encoding gene (FNDC5) associates with hepatic steatosis by differential miRNA binding to the 3′ UTR M Metwally, A Bayoumi, M Romero-Gomez, K Thabet, M John, LA Adams, ... Journal of hepatology 70 (3), 494-500, 2019 | 73 | 2019 |
| Impaired brain glymphatic flow in experimental hepatic encephalopathy A Hadjihambi, IF Harrison, M Costas-Rodríguez, F Vanhaecke, N Arias, ... Journal of hepatology 70 (1), 40-49, 2019 | 66 | 2019 |
| Increased soluble CD 36 is linked to advanced steatosis in nonalcoholic fatty liver disease C García‐Monzón, O Lo Iacono, J Crespo, M Romero‐Gómez, ... European journal of clinical investigation 44 (1), 65-73, 2014 | 58 | 2014 |
| Epigenetic mechanisms in non-alcoholic fatty liver disease: An emerging field R Gallego-Durán, M Romero-Gómez World journal of hepatology 7 (24), 2497, 2015 | 56 | 2015 |
| Lactulose reduces bacterial DNA translocation, which worsens neurocognitive shape in cirrhotic patients with minimal hepatic encephalopathy A Moratalla, J Ampuero, P Bellot, R Gallego‐Durán, P Zapater, M Roger, ... Liver International 37 (2), 212-223, 2017 | 46 | 2017 |
| Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta … FE Mózes, JA Lee, Y Vali, O Alzoubi, K Staufer, M Trauner, R Paternostro, ... The Lancet Gastroenterology & Hepatology 8 (8), 704-713, 2023 | 45 | 2023 |
| Imaging biomarkers for steatohepatitis and fibrosis detection in non-alcoholic fatty liver disease R Gallego-Durán, P Cerro-Salido, E Gomez-Gonzalez, MJ Pareja, ... Scientific Reports 6 (1), 31421, 2016 | 45 | 2016 |
